nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimetrexate—DHFR—uterine cervix—fallopian tube cancer	0.206	0.206	CbGeAlD
Trimetrexate—DHFR—endometrium—fallopian tube cancer	0.187	0.187	CbGeAlD
Trimetrexate—DHFR—uterus—fallopian tube cancer	0.172	0.172	CbGeAlD
Trimetrexate—DHFR—female reproductive system—fallopian tube cancer	0.155	0.155	CbGeAlD
Trimetrexate—DHFR—female gonad—fallopian tube cancer	0.141	0.141	CbGeAlD
Trimetrexate—DHFR—vagina—fallopian tube cancer	0.14	0.14	CbGeAlD
